We utilized this assay to test the efficacy of a newly developed SSCI, LM-4131, relative to two clinically effective COX-2 inhibitors, LMX and Celecoxib, to reduce basal and stress-induced anxiety-like behavior in mice. Here, PTGS2 is linked to Anxiety.